Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO)

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

March 31, 2010

Conditions
Breast Cancer
Interventions
DRUG

Goserelin

Trial Locations (1)

18075

Universitätsfrauenklinik, Rostock Universität, Rostock

All Listed Sponsors
lead

GBG Forschungs GmbH

OTHER

NCT00196846 - Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO) | Biotech Hunter | Biotech Hunter